Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 19/20 | 0.57 |
| ▸ | FKBP5 | Q13451 | 9/20 | 0.57 |
| ▸ | FKBP4 | Q02790 | 7/20 | 0.57 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL418765 | 1.00 | FKBP1A (0.57) | FKBP1AFKBP5FKBP4CRBN | |
| SCHEMBL418445 | 0.92 | FKBP1A (0.55) | FKBP1AFKBP5FKBP4CRBN | |
| SCHEMBL418446 | 0.92 | FKBP1A (0.55) | FKBP1AFKBP5FKBP4CRBN | |
| SCHEMBL10027166 | 0.91 | FKBP1A (0.63) | FKBP1AFKBP5FKBP4CRBN | |
| SCHEMBL419434 | 0.87 | FKBP1A (0.48) | FKBP1AFKBP5FKBP4CRBN | |
| SCHEMBL419433 | 0.87 | FKBP1A (0.48) | FKBP1AFKBP5FKBP4CRBN | |
| SCHEMBL419435 | 0.87 | FKBP1A (0.48) | FKBP1AFKBP5FKBP4CRBN | |
| SCHEMBL419432 | 0.87 | FKBP1A (0.48) | FKBP1AFKBP5FKBP4CRBN | |
| SCHEMBL10060886 | 0.87 | FKBP1A (0.60) | FKBP1AFKBP5FKBP4CRBN | |
| SCHEMBL10027167 | 0.85 | FKBP1A (0.64) | FKBP1AFKBP5FKBP4CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120022040-A1 | ANTIMICROBIALS | AMPLYX PHARMACEUTICALS, INC. | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022040-A1 | ANTIMICROBIALS | PAM, MPO, OXA1L | FKBP1A 4606/4885FKBP5 4666/4885FKBP4 4624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.